Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Total Liabilities: 2016-2019

Historic Total Liabilities for Monopar Therapeutics (MNPR) over the last 4 years, with Dec 2019 value amounting to $724,165.

  • Monopar Therapeutics' Total Liabilities rose 37.38% to $664,468 in Q3 2020 from the same period last year, while for Sep 2020 it was $664,468, marking a year-over-year increase of 37.38%. This contributed to the annual value of $724,165 for FY2019, which is 81.24% up from last year.
  • Monopar Therapeutics' Total Liabilities amounted to $724,165 in FY2019, which was up 81.24% from $399,551 recorded in FY2018.
  • In the past 5 years, Monopar Therapeutics' Total Liabilities registered a high of $724,165 during FY2019, and its lowest value of $64,510 during FY2016.
  • Over the past 3 years, Monopar Therapeutics' median Total Liabilities value was $399,551 (recorded in 2018), while the average stood at $478,528.
  • Data for Monopar Therapeutics' Total Liabilities shows a peak YoY surged of 383.44% (in 2017) over the last 5 years.
  • Over the past 4 years, Monopar Therapeutics' Total Liabilities (Yearly) stood at $64,510 in 2016, then spiked by 383.44% to $311,867 in 2017, then rose by 28.12% to $399,551 in 2018, then soared by 81.24% to $724,165 in 2019.